Mustafa Seyyar

14PUBLICATIONS

194CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersNutrigenomics and personalised nutrition

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 25, 2026

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 27, 2026

Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.

|May 27, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|Feb 27, 2026

Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study.

Mehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz

|Feb 11, 2026

Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Nov 17, 2025

Real-world comparison of doxorubicin-ifosfamide versus gemcitabine-docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study.

Salih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel

Pageof 3

Frequent Collaborators

Elif Sahin

Nargiz Majidova

Ali Kalem

Umut Kefeli

Sedat Biter

Devrim Cabuk

Caner Acar

Havva Yesil Cinkir

Haydar Cagatay Yuksel

3 joint publications

Salih Tünbekici

Frequent Collaborators

Elif Sahin

Nargiz Majidova

Ali Kalem

Umut Kefeli